Skip to main content

Harper-Denson Craig's Form 4/A amendment

Amended

Charge Enterprises, Inc. (CRGE) · filed Jul 21, 2022

Accession no.
0001654954-22-009936
Filed
Jul 21, 2022
Trade date
Jul 5, 2022
Filing delay
16 days
Rule 10b5-1 plan
Not on the form (before 2023)
Original filed
Jul 6, 2022

This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $55.6K. It was filed 16 days after the trade.

This amendment replaces 0001654954-22-009308 (filed Jul 6, 2022).

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Harper-Denson CraigCIK 0001872307Director, Officer (COO, CCO, Secretary)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 5, 2022Common Stock, par value $0.0001MOption exerciseAcquired+12,500$0.55+$6,87512,500Indirect
Jul 5, 2022Common Stock, par value $0.0001GGiftDisposed−12,500$0.00F1$012,500Indirect
Jul 5, 2022Common Stock, par value $0.0001GGiftAcquired+12,500$0.00F1$012,500Direct
Jul 5, 2022Common Stock, par value $0.0001SSaleDisposed−12,500$4.45F1−$55,6250Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 5, 2022Common StockMOption exerciseDisposed−12,500$0.00$09,737,500Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range. This Form 4 is being amended to reflect that the shares issued upon exercise of the option were gifted to the Reporting Person by Reporting Person's spouse and Reporting Person, as direct owner, disposed of the shares. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 1, 2022.

Referenced by the price of 3 transactions in Table I.

F2

On November 1, 2020, the Reporting Person's spouse was issued a ten-year option to purchase 10,500,000 shares of common stock. The vesting schedule for the remaining shares issuable upon exercise is: (i) 4,487,500 shares, which vested November 1, 2021; (ii) 2,625,000 shares will vest on November 1, 2022; and (iii) 2,625,000 shares will vest on November 1, 2023.

Read the full filing on SEC EDGAR (opens in a new tab)